MedTrace Logo

Effect of Metformin on Patients With Polycystic Ovary Syndrome

NCT05802212 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 77

Last updated 2025-11-25

No results posted yet for this study

Summary

The purpose of the study is to understand the effect of Metformin on patients with PCOS.

Conditions

  • PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

Interventions

DRUG

Metformin intervention for 12 weeks

PCOS patients were treated with metformin orally for 12 weeks, and various indicators related to fertility were observed.

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Principal Investigators

  • Qiaojie, Professor · Peking University Third Hospital

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2022-06-01
Completion
2023-05-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05802212 on ClinicalTrials.gov